Quarterly Result14 May 2026, 05:52 pm
Shree Ganesh Biotech: FY26 Revenue ₹497.05 Lakhs
AI Summary
Shree Ganesh Biotech (India) Ltd's audited financial results for the year ended March 31, 2026, show a total income of ₹644.27 lakhs and total expenses of ₹592.86 lakhs. The company reported a net profit after tax of ₹37.76 lakhs. Gross revenue from the sale of products was ₹497.05 lakhs. The Board meeting, which commenced and concluded on May 14, 2026, approved these results with an unmodified audit opinion.
Key Highlights
- Audited financial results for FY26 approved with unmodified opinion.
- Gross revenue from product sales reached ₹497.05 lakhs for FY26.
- Net profit after tax reported at ₹37.76 lakhs for the fiscal year.
- Total income for FY26 stood at ₹644.27 lakhs.
- Board meeting concluded on May 14, 2026, at 05:30 PM.
Price Impact
More from SHREEGANES